Hillary Clinton All Bark, No Bite with Biotech Tweet
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Stocks fall as higher oil prices, Treasury yields weigh
- Oppenheimer sees AI software winners as focus shifts to ROI
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
Market Reaction to Clinton Proposals Seen as 'Premature' and 'Overdone' - TD Securities (VRX)
September 23, 2015 11:42 AM EDTTD Securities maintained a Buy rating on Valeant Pharmaceuticals (NYSE: VRX) with a price target of $300. Analyst Lennox Gibbs called the market's reaction to proposals from presidential candidate Hillary Clinton premature and overdone.
Gibbs views plans to authorize Medicare to negotiate prices with drug manufacturers as the most noteworthy of Clinton's proposals, and he pointed out that Valeant derives an estimated 1520% of its revenues from Medicare.
"Drug stocks are down 3% since... More
Hillary Clinton Tweet Doesn't Change Bullish View on Valeant Pharmaceuticals (VRX), BMO Capital Says
September 21, 2015 1:57 PM EDTBMO Capital analyst Alex Arfaei weighed in on Valeant Pharmaceuticals (NYSE: VRX) which is down 6% in response to a Tweet from Hillary Clinton referring to this article in the... More
UPDATE: Biotech Bounces Off Lows (IBB)
September 21, 2015 1:19 PM EDT(Updated - September 21, 2015 1:29 PM EDT)
Biotech stocks bounced off lows Monday afternoon, paring declines that were largely driven by fears of increased government regulation of drug pricing. The source of concern was a tweet by presidential candidate Hillary Clinton... More
